Consensus scoring-based virtual screening and molecular dynamics simulation of some TNF-alpha inhibitors

Ndayisaba, 2019, TNFα inhibitors as targets for protective therapies in MSA: a viewpoint, J Neuroinflammation, 16, 80, 10.1186/s12974-019-1477-5 Lu, 2015, The TNFα converting enzyme (TACE) from ayu (Plecoglossus altivelis) exhibits TNFα shedding activity, Mol Immunol, 63, 497, 10.1016/j.molimm.2014.10.010 Zhao, 2001, Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis, Dev Biol, 232, 204, 10.1006/dbio.2001.0176 Yoda, 2013, Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivo, PLoS One, 8, e54412, 10.1371/journal.pone.0054412 Ribeiro, 2019, Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis, Inflamm. Res. Off. J. Eur. Histamine Res. Soc. ... [et al., 68, 1049 Holbrook, 2019, Tumour necrosis factor signalling in health and disease, F1000Research, 8, 10.12688/f1000research.17023.1 Dittrich, 2020, TNF-α signaling: TACE inhibition to put out the burning heart, PLoS Biol, 18, e3001037, 10.1371/journal.pbio.3001037 Tian, 2018, CASTp 3.0: computed atlas of surface topography of proteins, Nucleic Acids Res, 46, W363, 10.1093/nar/gky473 Hsu, 2011, iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis, BMC Bioinf, 12 Suppl 1, S33, 10.1186/1471-2105-12-S1-S33 Trott, 2010, “AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J Comput Chem, 31, 455, 10.1002/jcc.21334 Vilar, 2008, Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery, Curr Top Med Chem, 8, 1555, 10.2174/156802608786786624 Adelusi, 2021, Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches, silico Pharmacol., 9, 39, 10.1007/s40203-021-00100-2 Adelusi, 2021, Molecular dynamics , molecular mechanics , and density functional theory, J Mol Struct, 131879 Adelusi, 2021, 5, 778 Isaac, 2021, ( Mpro )– Molecular dynamics , molecular mechanics , and density functional theory investigations, J Mol Struct, xxxx, 131879 Radner, 2015, Anti-TNF in rheumatoid arthritis: an overview, Wien Med Wochenschr, 165, 3, 10.1007/s10354-015-0344-y Tzanavari, 2010, TNF-alpha and obesity, Curr Dir Autoimmun, 11, 145, 10.1159/000289203 He, 2005, Small-molecule inhibition of TNF-alpha, Science, 310, 1022, 10.1126/science.1116304 Boyenle, 2021, Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: a review on in silico perspective, Pharmacol Res, 167, 105577, 10.1016/j.phrs.2021.105577 dos Santos Maia, 2020, Consensus analyses in molecular docking studies applied to medicinal chemistry, Mini Rev Med Chem, 20, 1322, 10.2174/1389557520666200204121129 Halim, 2021, Structure-based virtual screening of tumor necrosis factor-α inhibitors by cheminformatics approaches and bio-molecular simulation, Biomolecules, 11, 10.3390/biom11020329 Sargsyan, 2017, How molecular size impacts RMSD applications in molecular dynamics simulations, J Chem Theor Comput, 13, 1518, 10.1021/acs.jctc.7b00028 Lobanov, 2008, [Radius of gyration is indicator of compactness of protein structure], Mol Biol, 42, 701, 10.1134/S0026893308040195 Chen, 2016, Regulation of protein-ligand binding affinity by hydrogen bond pairing, Sci Adv, 2, e1501240, 10.1126/sciadv.1501240 Fischer, 2021, Decision making in structure-based drug discovery: visual inspection of docking results, J Med Chem, 64, 2489, 10.1021/acs.jmedchem.0c02227 Thangsunan, 2020, Effective prediction model and determination of binding residues influential for inhibitors targeting HIV-1 integrase-LEDGF/p75 interface by employing solvent accessible surface area energy as key determinant, J Biomol Struct Dyn, 38, 460, 10.1080/07391102.2019.1580219 Ferreira, 2019, ADMET modeling approaches in drug discovery, Drug Discov Today, 24, 1157, 10.1016/j.drudis.2019.03.015 Di, 2003, Profiling drug-like properties in discovery research, Curr Opin Chem Biol, 7, 402, 10.1016/S1367-5931(03)00055-3 Lamothe, 2016, The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage, J Biol Chem, 291, 20387, 10.1074/jbc.M116.743138 Walker, 1999, Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states, Br J Pharmacol, 128, 444, 10.1038/sj.bjp.0702774 Lipinski, 2004, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discov Today Technol, 1, 337, 10.1016/j.ddtec.2004.11.007